EDITORIAL
Accepted on 05 Sep 2025
Editorial
doi 10.3389/fneur.2025.1687550
- Frontiers in Neurology
- Neurological Biomarkers
- Research Topics
- Autoantibodies and autoimmune neuromuscular disorders
Autoantibodies and autoimmune neuromuscular disorders
4,148
Total downloads
23k
Total views and downloads
Articles
MINI REVIEW
Published on 17 Jul 2025
Emerging B and plasma cell-targeting immune therapies in idiopathic inflammatory myopathies
doi 10.3389/fimmu.2025.1581323
- 1,859 views
ORIGINAL RESEARCH
Published on 17 Apr 2025
Efgartigimod as a fast-acting treatment in generalized very-late-onset myasthenia gravis
doi 10.3389/fimmu.2025.1579859
- 2,123 views
ORIGINAL RESEARCH
Published on 24 Mar 2025
Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect
doi 10.3389/fimmu.2025.1549034
- 2,465 views
- 1 citation
CORRECTION
Published on 12 Feb 2025
Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
doi 10.3389/fneur.2025.1567315
- 729 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
doi 10.3389/fneur.2024.1504260
- 7,500 views
- 1 citation
CASE REPORT
Published on 07 Oct 2024
Case report: target antigen and subclass switch in a patient with autoimmune nodopathy
doi 10.3389/fimmu.2024.1475478
- 1,664 views
ORIGINAL RESEARCH
Published on 13 Sep 2024
Exhausted signature and regulatory network of NK cells in myasthenia gravis
doi 10.3389/fimmu.2024.1397916
- 2,529 views
- 3 citations
Published in
Frontiers in Neurology
Neurological Biomarkers
Participating Journals
Frontiers in Immunology
- 5.9 impact factor
- 10.8 citescore